Filing Details
- Accession Number:
- 0001570523-18-000018
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2018-03-30 16:17:32
- Reporting Period:
- 2017-12-31
- Accepted Time:
- 2018-03-30 16:17:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1559356 | Immune Therapeutics Inc. | IMUN | Pharmaceutical Preparations (2834) | 593226705 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1570523 | Jackman Robert Dailey | 401 First Street Los Altos CA 94022 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-15 | 1,000 | $0.12 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-16 | 6,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-16 | 1,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-16 | 5,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-16 | 1,100 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-17 | 1,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-17 | 1,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-24 | 2,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-25 | 1,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-26 | 5,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-26 | 5,200 | $0.12 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-26 | 1,200 | $0.12 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-26 | 1,000 | $0.12 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-26 | 1,000 | $0.12 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-02 | 30,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-02 | 10,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-02 | 9,000 | $0.11 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-02 | 1,000 | $0.12 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-02 | 1,000 | $0.10 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-02 | 20,000 | $0.10 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-02 | 1,000 | $0.12 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-09 | 1,000 | $0.12 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-09 | 3,000 | $0.13 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-12 | 1,000 | $0.12 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-13 | 1,000 | $0.12 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-16 | 1,000 | $0.10 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-19 | 2,260 | $0.10 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-27 | 1,000 | $0.10 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-27 | 10,000 | $0.10 | 20,800,359 | No | 5 | P | Direct | |
| Common Stock | Acquisiton | 2016-09-27 | 20,000 | $0.11 | 20,800,359 | No | 5 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct | |
| No | 5 | P | Direct |
Billionaire Hedge Funds
